HK130297A - Process and intermediate for the preparation of terazosin hydrochloride dihydrate - Google Patents

Process and intermediate for the preparation of terazosin hydrochloride dihydrate

Info

Publication number
HK130297A
HK130297A HK130297A HK130297A HK130297A HK 130297 A HK130297 A HK 130297A HK 130297 A HK130297 A HK 130297A HK 130297 A HK130297 A HK 130297A HK 130297 A HK130297 A HK 130297A
Authority
HK
Hong Kong
Prior art keywords
tetrahydrofuroyl
dimethoxy
amino
preparation
hydrochloride dihydrate
Prior art date
Application number
HK130297A
Other languages
English (en)
Inventor
Anthony Mannino
Wayne R Heitmann
Rodger F Henry
Bruce W Horrom
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23264439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK130297(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HK130297A publication Critical patent/HK130297A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK130297A 1994-10-18 1997-06-26 Process and intermediate for the preparation of terazosin hydrochloride dihydrate HK130297A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/324,635 US5504207A (en) 1994-10-18 1994-10-18 Process and intermediate for the preparation of terazosin hydrochloride dihydrate

Publications (1)

Publication Number Publication Date
HK130297A true HK130297A (en) 1997-09-19

Family

ID=23264439

Family Applications (1)

Application Number Title Priority Date Filing Date
HK130297A HK130297A (en) 1994-10-18 1997-06-26 Process and intermediate for the preparation of terazosin hydrochloride dihydrate

Country Status (11)

Country Link
US (1) US5504207A (pt)
EP (1) EP0708104B1 (pt)
JP (1) JP2711230B2 (pt)
AT (1) ATE143959T1 (pt)
BR (1) BR1100705A (pt)
CA (1) CA2143971C (pt)
DE (1) DE69500064T2 (pt)
DK (1) DK0708104T3 (pt)
ES (1) ES2089993T3 (pt)
GR (2) GR960300047T1 (pt)
HK (1) HK130297A (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
DE19546573A1 (de) * 1995-12-13 1997-06-19 Uetikon Chemie Gmbh Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
DK0849266T3 (da) * 1996-12-20 2007-06-04 Heumann Pcs Gmbh Hidtil ukendt polymorf form af doxazosin-mesylat (form III)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
US6248888B1 (en) * 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
US20070161791A1 (en) * 2006-01-09 2007-07-12 Narsimha Reddy Penthala Process for the preparation of terazosin hydrocloride dihydrate
CN101547696A (zh) * 2006-08-08 2009-09-30 奥斯拜客斯制药有限公司 具有α肾上腺素能阻断效应的取代喹唑啉化合物的制备和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
CA2071915A1 (en) * 1990-08-23 1992-02-24 Tadao Shoji Antiviral agent
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 1−(4−アミノ−6,7−ジメトキシ−2−キナゾリニル)−4−(2−テトラヒドロフロイル)ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition

Also Published As

Publication number Publication date
EP0708104A1 (en) 1996-04-24
ES2089993T1 (es) 1996-10-16
EP0708104B1 (en) 1996-10-09
JPH08134066A (ja) 1996-05-28
ATE143959T1 (de) 1996-10-15
DE69500064D1 (de) 1996-11-14
CA2143971A1 (en) 1996-04-19
DK0708104T3 (da) 1997-03-10
GR960300047T1 (en) 1996-08-31
JP2711230B2 (ja) 1998-02-10
GR3021319T3 (en) 1997-01-31
DE69500064T2 (de) 1997-04-10
ES2089993T3 (es) 1997-02-16
US5504207A (en) 1996-04-02
CA2143971C (en) 1997-06-03
BR1100705A (pt) 1999-10-13

Similar Documents

Publication Publication Date Title
HK130297A (en) Process and intermediate for the preparation of terazosin hydrochloride dihydrate
EA199900953A1 (ru) ЗАМЕЩЕННЫЕ ПИРАЗОЛЫ, КАК ИНГИБИТОРЫ p38 КИНАЗЫ
RS65604A (en) Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
NO20005641D0 (no) En fremgangsmåte og en anordning i et trådlöst kommunikasjonssystem
NO985377D0 (no) FremgangsmÕte for Õ fremstille polyalkenaminer
MXPA02011458A (es) Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos.
EA200100554A1 (ru) Замещенные пиразолы как ингибиторы p38 киназы
AU8870601A (en) A method for treating allergies using substituted pyrazoles
ATE440078T1 (de) Verfahren zur herstellung von alkylaminen
ATE251195T1 (de) In-situ herstellung von polyasparaginestermischungen
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
MXPA03008811A (es) Procedimiento para la preparacion de 4,6-diaminopirimido (5,4-d) pirimidinas.
ATE337607T1 (de) Chipkondensator und verfahren zu dessen herstellung
ATE440088T1 (de) Verfahren zur herstellung von 4-(3'-chlor-4'- fluoranilino)-7-methoxy-6-(3- morpholinopropoxy)chinazolin
ATE253550T1 (de) In-situ herstellung einer polyasparaginsäureestermischung
ATE244134T1 (de) Verfahren zur brikettierung von metallspänen und brikettierpresse
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
ATE446952T1 (de) Herstellungsverfahren von 2-cyanopyridinen
HK1027560A1 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
ES2089971A1 (es) Procedimiento de preparacion de 2-(4-/4-(cloro-1-pirazolil) butil/1-piperacinil) pirimidina (lesopitron).
IL153144A0 (en) Method for preparing substituted 5-amino-n-phenyl-1,2,4-triazole-3-sulfonamides
HUP0203878A2 (hu) Eljárás heterociklusos vegyületek előállítására
IL158530A0 (en) Method for producing 1,3-disubstituted 2-nitroguanidines
YU175483A (en) Process for obtining crystlline 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-piperazine hydrochloride

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20050306

ARF Application filed for restoration

Effective date: 20060620

ARG Restoration of standard patent granted

Effective date: 20060809

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140306